Analyst/ Investor Meet on Tuesday, September 01, 2026

Emcure Ref: EPL/CS/SE/0071/2026 Date: August 07, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation of schedule of Analyst/ Investor Meeting(s) Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find below proposed schedule of participation in Investor Conferences by Officials of the Company: Day & Date Name of Analysts/ Investor City Type of (Institutional/ Individual)/ Event Meeting Wednesday, August 12, 2026 Emkay ‘Confluence 2026’ Conference Tuesday, August 18, 2026 Motilal Oswal 22nd Annual Global Group and Investor Conference, 2026 Mumbai One-on-one Meeting Tuesday, September 01, 2026 Elara India Dialogue 2026 Conference Thursday, September 17, 2026 Kotak Healthcare Forum 2026 Tuesday, September 22, 2026 11th Annual J.P. Morgan India Conference The schedule is tentative, and changes may happen due to exigencies on the part of Investors/Company. No unpublished price sensitive information is proposed to be shared / discussed with aforesaid analyst/ investors during the meeting. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer ICSI Membership Number: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251